Stockreport
Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q1 2018 Results - Earnings Call Transcript [Seeking Alpha]
Last lexicon pharmaceuticals earnings: 5/3 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: lexpharma.com/investors
PDF
Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q1 2018 Results - Earnings Call Transcript
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | LXRX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
LXRX alerts
LXRX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
LXRX alerts
High impacting LEXICON PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics
LXRX
NEWS
NEWS
- Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "buy" rating re-affirmed by analysts at Wedbush. They now have a $42.00 price target on the stock.[MarketBeat]
- Lexicon Pharmaceuticals to Present New Clinical Data at 78th American Diabetes Association Scientific Sessions[GlobeNewswire]
- Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating.[MarketBeat]
- Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating.[MarketBeat]
- Lexicon Pharmaceuticals to Present at Upcoming Investor Conference[GlobeNewswire]
- More
LXRX
SEC Filings
SEC Filings
- 6/21/18 - Form 4
- 6/18/18 - Form 4
- 6/12/18 - Form 4
- LXRX's page on the SEC website
- More